Literature DB >> 2111933

Sickle cell anaemia trial.

M H Gaston1, J Verter.   

Abstract

The major cause of death in sickle cell anaemia is from infection, especially infection caused by Streptococcus pneumoniae. Meningitis, pneumonia and septicaemia caused by this organism are the primary types of infection leading to death. Children under three years of age are at highest risk. We have known for over twenty years that approximately 30 per cent of the infants born with sickle cell anaemia will become infected in the first three years of life and one-third can be expected to die from the infection. These data were the reason that we conducted the Prophylactic Penicillin Study (PROPS), a trial to investigate the effectiveness of oral prophylactic penicillin in preventing severe infection due to S. pneumoniae. This investigation was a very efficient, cost effective study because of its timeliness and its conduct within the framework of an ongoing study. Moreover, the question being answered was simple and focused with up-to-date data that permitted accurate estimates of sample size and incidence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111933     DOI: 10.1002/sim.4780090111

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

Review 1.  Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.

Authors:  Angela E Rankine-Mullings; Shirley Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2017-10-10

2.  Evaluation of caries-associated virulence of biofilms from Candida albicans isolated from saliva of pediatric patients with sickle-cell anemia.

Authors:  Fernanda Lourenção Brighenti; Amanda Coelho Medeiros; Bruno Mello Matos; Zulene Eveline Abreu Ribeiro; Cristiane Yumi Koga-Ito
Journal:  J Appl Oral Sci       Date:  2014 Nov-Dec       Impact factor: 2.698

3.  Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.

Authors:  Angela E Rankine-Mullings; Shirley Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2021-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.